A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study Article

Prados, MD, Lamborn, K, Yung, WKA et al. (2006). A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study . NEURO-ONCOLOGY, 8(2), 189-193. 10.1215/15228517-2005-010

Open Access

cited authors

  • Prados, MD; Lamborn, K; Yung, WKA; Jaeckle, K; Robins, HI; Mehta, M; Fine, HA; Wen, PY; Cloughesy, T; Chang, S; Nicholas, MK; Schiff, D; Greenberg, H; Junck, L; Fink, K; Hess, K; Kuhn, J

sustainable development goals

authors

publication date

  • April 1, 2006

published in

keywords

  • ADULTS
  • CHEMOTHERAPY
  • Clinical Neurology
  • Life Sciences & Biomedicine
  • METABOLITE
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology
  • clinical trial
  • irinotecan
  • phase 2
  • recurrent malignant glioma

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 189

end page

  • 193

volume

  • 8

issue

  • 2